February 13, 2017

The Antitrust Week In Review

Here are some of the developments in antitrust news this past week that we found interesting and are following.

U.S. Court Blocks Anthem-Cigna Merger, Dealing Blow to Consolidation.  A federal judge on Wednesday ruled against U.S. health insurer Anthem’s proposed $54 billion merger with smaller rival Cigna, derailing an unprecedented effort to consolidate the country’s health insurance industry.  The U.S. Justice Department sued in July to stop Anthem’s purchase of Cigna, a deal that would have created the largest U.S. health insurer by membership, and Aetna’s planned $33 billion acquisition of Humana.  The merger would have worsened an already highly concentrated market and is likely to raise prices, Judge Amy Berman Jackson of the U.S. District Court for the District of Columbia said while issuing the ruling against Anthem’s deal.

Tyson Reveals SEC Subpoena, Likely Tied to Pricing Lawsuits.  Tyson Foods says it has been subpoenaed by federal regulators, likely related to an investigation in connection with allegations that the company and others colluded to fix poultry prices.  The Springdale, Arkansas-based meat producer said in a regulatory filing it received the subpoena Jan. 20 from the Securities and Exchange Commission.  It said it is cooperating with the investigation, which is in an “early stage.”

BT Supports Google’s Android in EU Antitrust Row.  BT has become the first major telecoms company to back Google in a battle with EU regulators, defending the “stability and compatibility” of the Android operating system, which is in the sights of antitrust regulators.  The EU says Google stifles competition by forcing smartphone makers to pre-install its search function and browser to access its other apps, such as Google Play, on Android.  EU regulators were already investigating the U.S. company over the promotion of its own shopping service in its search engine before they opened a second front last year.

Mylan Agreed to Pay $96.5 Mln in Provigil Antitrust Class Action.  Mylan has agreed to pay $96.5 million to settle claims by drug purchasers that it delayed launching a generic version of Cephalon’s narcolepsy drug Provigil in exchange for payment from Cephalon.  The settlement was disclosed in a filing by the drug purchasers in Pennsylvania federal court on Friday and must still be approved by the court.  The money will go to purchasers that bought brand-name Provigil from Cephalon directly, like wholesalers and distributors.

Leave a comment »

Categories: Antitrust Litigation, International Competition Issues

    February 7, 2017

    EU Launches Three Antitrust Investigations Into E-Commerce

    A View from Constantine Cannon’s London Office

    By Richard Pike and Yulia Tosheva

    On Thursday, the EU Commission launched three separate investigations into suspected anticompetitive practices in the online sales of consumer electronics, video games and hotel accommodation.

    The launch of these investigations does not come as a surprise.  On September 15, 2016, the Commission published a Preliminary Report following its sector inquiry into e-commerce which identified retail price restrictions, discrimination on the basis of location and geo-blocking practices as areas of concern.

    During the sector inquiry, the Commission gathered evidence from nearly 1,800 companies operating in e-commerce sales of consumer goods and digital content and analysed around 8,000 distribution contracts.  The inquiry is part of the EC’s wider Digital Single Market Strategy, which was adopted on May 6, 2015.  As this blog discussed, the goal of the Digital Single Market is to ensure better access for consumers and businesses to digital goods and services across Europe, and create a level playing field for digital networks and innovative services.

    click here for more »

    Leave a comment »

    Categories: Antitrust Enforcement, International Competition Issues

      February 6, 2017

      The Antitrust Week In Review

      Here are some of the developments in antitrust news this past week that we found interesting and are following.

      Drug Makers Accused of Fixing Prices on Insulin.  A lawsuit has been filed accusing three makers of insulin of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills.  The price of insulin has skyrocketed in recent years, with the three manufacturers — Sanofi, Novo Nordisk and Eli Lilly — raising the list prices of their products in near lock step, prompting outcry from patient groups and doctors who have pointed out that the rising prices appear to have little to do with increased production costs.  The lawsuit, filed in federal court in Massachusetts, accuses the companies of exploiting the country’s opaque drug-pricing system in a way that benefits themselves and the intermediaries known as pharmacy benefit managers.

      EU Probes Online Sales in Electronics, Video Games, Hotels.  EU antitrust regulators opened three investigations on Thursday into 15 companies suspected of restricting online sales of electronics, video games and hotel rooms to deny consumers choice and prevent them from buying at the lowest prices.  The EU aims to boost online cross-border sales and stop “geo-blocking” — restricting offers based on a customer’s location — which runs counter to its goal of a single market for digital goods and services that would underpin economic growth.  “E-commerce should give consumers a wider choice of goods and services, as well as the opportunity to make purchases across borders,” European Competition Commissioner Margrethe Vestager said in a statement.

      NCAA Agrees to Pay $208 Million Settlement in Antitrust Case.  The NCAA and 11 major athletic conferences announced Friday night they have agreed to pay $208.7 million to settle a federal class-action antitrust lawsuit filed by former college athletes who claimed the value of their scholarships was illegally capped.  The settlement still must be approved by a judge and it does not close the antitrust case.  The NCAA said in a statement the association and conferences “will continue to vigorously oppose the remaining portion of the lawsuit seeking pay for play.”

      Walgreens and Rite Aid Cut Price of Merger.  Concerns about regulatory approval have weighed on Walgreens Boots Alliance’s bid to buy a top drugstore rival, Rite Aid, as the two cut the price of the deal while pushing back the expected closing date by six months.  In a joint statement, the retailers said that they would cut the price of the takeover to between $6.50 a share and $7 a share, potentially revaluing the transaction to as little as $6.8 billion.  When the transaction was announced in 2015, Walgreens had agreed to pay $9 a share, or $9.4 billion.

      Leave a comment »

      Categories: Uncategorized

        January 30, 2017

        The Antitrust Week In Review

        Here are some of the developments in antitrust news this past week that we found interesting and are following.

        Amazon Offers to Scrap E-book Clauses to Settle EU Antitrust Probe.  Amazon has offered to alter its e-book contracts with publishers in a bid to end an EU antitrust probe and stave off a possible fine, the European Commission said on Tuesday.  Amazon, the biggest e-book distributor in Europe, proposed to drop some clauses in its contracts so publishers will not be forced to give it terms as good as those for rivals, the Commission said.  Such clauses relate to business models, release dates, catalogs of e-books, features of e-books, promotions, agency prices, agency commissions and wholesale prices.

        Judge Blocks Aetna’s $37 Billion Deal for Humana.  A federal judge ruled that a $37 billion merger between the health insurance giants Aetna and Humana should not be allowed to go through on antitrust grounds, siding with the U.S. Justice Department, which had been seeking to block the deal.  The deal is one of two mega-mergers proposed by the nation’s largest health insurers; both were challenged by the Obama administration. Another federal judge is expected to rule soon on the case involving Anthem and Cigna, the larger of the two deals, at $48 billion.

        FTC Settles Pay-for-Delay Lawsuit, Files Two Related Complaints.  The U.S. Federal Trade Commission announced that it has settled allegations that Endo Pharmaceuticals violated antitrust law when it agreed to pay rivals Watson Laboratories and Impax to delay introducing generic versions of two painkillers.  The FTC filed charges against Watson, and Allergan Plc , accusing it of breaking the law by reaching an agreement with Endo to block a generic competitor for the local anesthetic Lidoderm.

        As Regulators Waver, Apple Takes on Qualcomm in Courts.  Apple’s new legal assault on Qualcomm in the United States and China reflects its conclusion that regulators are unlikely to put an end to what it considers the chip maker’s unfair business practices, according to analysts.  Apple has long objected to Qualcomm’s practice of charging for the “modem” chips that help phones use wireless networks data plans and its demands for a license fee based on the total price of the phones.  Qualcomm was the original inventor of a number of key wireless technologies.

        Leave a comment »

        Categories: Antitrust Enforcement, Antitrust Litigation, International Competition Issues

          January 23, 2017

          The Antitrust Week In Review

          Here are some of the developments in antitrust news this past week that we found interesting and are following.

          Apple Depicts Qualcomm as a Shady Monopolist in $1B Lawsuit.  Apple is suing mobile chip maker Qualcomm for $1 billion in a patent fight pitting the iPhone maker against one of its major suppliers.  The 100-page complaint filed Friday in a San Diego federal court depicts Qualcomm as a greedy monopolist abusing its power in a key segment of the mobile chip market to extort royalties for iPhone innovations that have nothing to do with Qualcomm’s technology.

          EU Antitrust Regulators Welcome Amazon, Apple Audiobook Deal.  A decision by Amazon and Apple to scrap all exclusivity obligations in the supply and distribution of audiobooks will likely boost competition, EU antitrust regulators said on Thursday.  The companies announced their decision on Jan. 5 after talks with the European Commission and the German Federal Cartel Office.  Such curbs had prompted a complaint from the German Publishers and Booksellers Association to both regulators, triggering an investigation by the German enforcer in November 2015.

          FTC Not Sold on Walgreens’ Plan to Win Nod for Rite Aid Deal: Bloomberg.  The U.S. Federal Trade Commission is not satisfied with Walgreens Boots Alliance Inc.’s plan to divest stores to win antitrust clearance for its acquisition of Rite Aid Corp, Bloomberg reported, citing people familiar with the matter.  The FTC is not convinced that Walgreen’s proposal to sell 865 drugstores to Fred’s Inc. would do enough to preserve competition that would be lost in the $9.4 billion tie-up, Bloomberg reported on Friday.

          U.S. Top Court Rejects Banks over Libor Antitrust Lawsuits.   The U.S. Supreme Court on Tuesday allowed private antitrust lawsuits brought by investors including big U.S. cities accusing major banks of conspiring to manipulate the pivotal Libor benchmark interest rate to move forward.  The justices rejected an appeal filed by a group of banks including Bank of America Corp., Deutsche Bank AG, UBS AG and JPMorgan Chase & Co. of a May 2016 ruling by the U.S. Court of Appeals for the Second Circuit that allowed various lawsuits against them to proceed.

          Leave a comment »

          Categories: Antitrust Enforcement, Antitrust Litigation

            « Previous Entries   Next Entries »

            © 2009-2017 Constantine Cannon LLP. Attorney Advertising. Disclaimer. Privacy Policy.